Live stream preview
Subject characteristics and changes in bone mineral density after transitioning from denosumab to alendronate in the denosumab adherence preference satisfaction (DAPS) study Prof Mike McClung
ANZ Bone and Mineral Society 2019 • 17m
Up Next in ANZ Bone and Mineral Society 2019
Lifestyle intervention for frail obes...
Osteal macrophage contributions to bo...
Natural Language Processing of radiol...